These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25118082)

  • 21. Does risperidone improve hyperacusia in children with autism?
    Ghanizadeh A
    Psychopharmacol Bull; 2009; 42(1):108-10. PubMed ID: 19204655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone and late onset tics.
    Feroz-Nainar C; Roy M
    Autism; 2006 May; 10(3):302-7. PubMed ID: 16682400
    [No Abstract]   [Full Text] [Related]  

  • 23. Risperidone in a very young child with PDD.
    Bober D; Sabzwari U; Star JE
    J Am Acad Child Adolesc Psychiatry; 2005 Aug; 44(8):725-6. PubMed ID: 16034272
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of autistic children with risperidone.
    Dodig-Curković K; Curković M; Radić J; Radić M
    Coll Antropol; 2011 Jan; 35 Suppl 1():297-301. PubMed ID: 21648351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of behavioral disorders by risperidone in children with autism].
    Wei BY; Huang F; Qin XT; Liang QQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Mar; 13(3):216-8. PubMed ID: 21426640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions.
    Correia CT; Almeida JP; Santos PE; Sequeira AF; Marques CE; Miguel TS; Abreu RL; Oliveira GG; Vicente AM
    Pharmacogenomics J; 2010 Oct; 10(5):418-30. PubMed ID: 19997080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal movements with the addition of clindamycin to risperidone in a girl with autism.
    Malone RP; Harvey JA
    J Child Adolesc Psychopharmacol; 2008 Apr; 18(2):221-2. PubMed ID: 18439121
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
    Del Casale A; Kotzalidis GD; Sacco M; Rapinesi C; De Giorgi R; Giardini M; D'Andreagiovanni M; Carlino N; Brugnoli R; Girardi P
    Psychiatr Danub; 2016 Mar; 28(1):91-4. PubMed ID: 26938829
    [No Abstract]   [Full Text] [Related]  

  • 30. Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.
    Zuddas A; Di Martino A; Muglia P; Cianchetti C
    J Child Adolesc Psychopharmacol; 2000; 10(2):79-90. PubMed ID: 10933118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary retention associated with aripiprazole: Report of a new case and review of the literature.
    Boyer MG; Kheloufi F; Denis J; Micallef J; Milh M
    Therapie; 2018; 73(3):287-289. PubMed ID: 29146041
    [No Abstract]   [Full Text] [Related]  

  • 32. Double-blind placebo-controlled trial of pentoxifylline added to risperidone: effects on aberrant behavior in children with autism.
    Akhondzadeh S; Fallah J; Mohammadi MR; Imani R; Mohammadi M; Salehi B; Ghanizadeh A; Raznahan M; Mohebbi-Rasa S; Rezazadeh SA; Forghani S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):32-6. PubMed ID: 19772883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Side-effects of risperidone therapy mimicking cerebrospinal fluid shunt malfunction: implications for clinical monitoring and management.
    Edwards RJ; Pople IK
    J Psychopharmacol; 2002 Jun; 16(2):177-9. PubMed ID: 12095077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risperidone-Induced Acute Respiratory Distress in an Adolescent with Autism.
    Chen F
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):851-852. PubMed ID: 27220113
    [No Abstract]   [Full Text] [Related]  

  • 36. Substituting traditional antipsychotics with risperidone for individuals with mental retardation.
    Simon EW; Blubaugh KM; Pippidis M
    Ment Retard; 1996 Dec; 34(6):359-66. PubMed ID: 8990820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
    Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
    Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifocal atrial tachycardia caused by risperidone.
    Oner T; Akdeniz C; Adaletli H
    Int J Cardiol; 2016 Jan; 203():855-7. PubMed ID: 26599751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone: a potential treatment for autism.
    Posey DJ; McDougle CJ
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1212-6. PubMed ID: 12211417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Gagliano A; Germanò E; Pustorino G; Impallomeni C; D'Arrigo C; Calamoneri F; Spina E
    J Child Adolesc Psychopharmacol; 2004; 14(1):39-47. PubMed ID: 15142390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.